Terms ending in 2042
Every in-force patent on Codexis, Inc.'s record whose computed term ends in 2042, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 11,898,174 | Engineered Uridine Phosphorylase Variant Enzymes In force · High confidence | Codexis, Inc. | In force | High confidence | |
| US 11,913,036 | Engineered Acetate Kinase Variant Enzymes In force · High confidence | Codexis, Inc. | In force | High confidence | |
| US 11,913,037 | Engineered Adenylate Kinase Variant Enzymes In force · High confidence | Codexis, Inc. | In force | High confidence | |
| US 12,180,483 | Engineered Cyclic Gmp-Amp Synthase (cGAS) Variant Enzymes In force · High confidence | Codexis, Inc. | In force | High confidence | |
| US 12,421,505 | Polynucleotides Encoding Engineered Acetate Kinase Variant Enzymes In force · High confidence | Codexis, Inc. | In force | High confidence | |
| US 11,970,722 | Engineered Acid Alpha-Glucosidase Variants In force · High confidence | Crosswalk Therapeutics, Inc. | In force | High confidence | |
| US 11,760,981 | Engineered Glycosyltransferases and Steviol Glycoside Glucosylation Methods In force · High confidence | Tate & Lyle Solutions USA LLC | In force | High confidence | |
| US 12,110,521 | Engineered Methionine Gamma Lyase Variants In force · High confidence | Syntis Bio, Inc. | In force | High confidence | |
| US 12,503,688 | Engineered Transaminase Polypeptides In force · High confidence | Codexis, Inc. | In force | High confidence | |
| US 12,473,557 | Engineered Guanylate Kinase Variant Enzymes In force · High confidence | Codexis, Inc. | In force | High confidence | |
| 4 more term ends in 2042 · Pro | |||||
10 of 14 patents shown. Soonest term end first, then patent number.
Pro members see all 14.
10 of these are in force and held by Codexis, Inc..
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.